Authors: Burstein, HJ Kuter, I Campos, SM Gelman, RS Tribou, L Parker, LM Manola, J Younger, J Matulonis, U Bunnell, CA Partridge, AH Richardson, PG Clarke, K Shulman, LN Winer, EP

Citation: Hj. Burstein et al., Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer, J CL ONCOL, 19(10), 2001, pp. 2722-2730

Authors: Bunnell, CA Supko, JG Eder, JP Clark, JW Lynch, TJ Kufe, DW Shulman, LN

Citation: Ca. Bunnell et al., Phase I clinical trial of 7-cyanoquinocarcinol (DX-52-1) in adult patientswith refractory solid malignancies, CANC CHEMOT, 48(5), 2001, pp. 347-355

Authors: Burstein, HJ Bunnell, CA Winer, EP

Citation: Hj. Burstein et al., New cytotoxic agents and schedules for advanced breast cancer, SEMIN ONCOL, 28(4), 2001, pp. 344-358

Authors: Burstein, HJ Manola, J Younger, J Parker, LM Bunnell, CA Scheib, R Matulonis, UA Garber, JE Clarke, KD Shulman, LN Winer, EP

Citation: Hj. Burstein et al., Docetaxel administered on a weekly basis for metastatic breast cancer, J CL ONCOL, 18(6), 2000, pp. 1212-1219

Authors: Yu, L Stephenson, GA Mitchell, CA Bunnell, CA Snorek, SV Bowyer, JJ Borchardt, TB Stowell, JG Byrn, SR

Citation: L. Yu et al., Thermochemistry and conformational polymorphism of a hexamorphic crystal system, J AM CHEM S, 122(4), 2000, pp. 585-591